Skip to main content
SpringerLink
Log in

Uremic Dysmetabolism and Its Effect on Immunocompetent and Erythroid Cell Function

  • Chapter
Uremic Toxins

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 223))

  • 74 Accesses

Abstract

From numerous of publications it is evident that an immunodeficiency exists in end-stage renal failure (ESRF) patients. To give a strict definition of these defects is, however, difficult.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. R.J. Glassock, Nutrition, immunology, and renal disease, Kidney Int. 26;Suppl. 16:194 (1985).

    Google Scholar 

  2. G.J. Laundy, and B.A. Bradley, Immunoglobulin allotypes in patients in end-stage renal failure, J Immunogenetics 12:181 (1985).

    Article  CAS  Google Scholar 

  3. R.F. Gagnon, J. Shuster, M. Kaye, Auto-immunity in patients with end-stage renal disease maintained on hemodialysis and continuous ambulatory peritoneal dialysis, J Clin Lab Immunol. 11:155 (1983).

    PubMed  CAS  Google Scholar 

  4. M.A. Watson, J.D. Briggs, A.A. Diamandopoulous, D.N.H. Hamilton and H.M. Dick, Endogenous cell-mediated immunity, blood transfusion and outcome of renal transplantation, Lancet. 1:1323 (1979).

    Article  Google Scholar 

  5. A.K. Cheung, and L.W. Henderson, Effects of complement activation by hemodialysis membranes. Am J Nephrol. 6: 81 (1986).

    Article  PubMed  CAS  Google Scholar 

  6. D.A. Casciato, L.P. McAdam, J.D. Kopple, R. Bluestone, L.S. Goldberg, P.J. Clements, and B.W. Knutson, Immunologic abnormalities in hemodialysis patients; Improvement after Pyridoxin therapy, Nephron. 38:9 (1984).

    Article  PubMed  CAS  Google Scholar 

  7. L.D. Antoniou, and R.J. Shalhoub, Zinc-induced enhance ment of lymphocyte function and viability in chronic uremia. Nephron. 40:13 (1985).

    Article  Google Scholar 

  8. K.S. Kleinman, and D.C. Zoschke, Suppression of human lymphocyte responses in chronic renal failure mediated by adherent cells: Analysis in serum-free media. J Lab Clin Med. 106:262 (1985).

    Google Scholar 

  9. T. Kunori, I. Feherman, O. Ringden, and E. Möller, In vitro characterization of immunological responseiveness, Nephron. 26:234 (1980).

    Google Scholar 

  10. J.E. Lortan, P. Kiepiela, H.M. Coovadia, and Y.K. Seedat, Suppressor cell assayed by numerical and functional tests in chronic renal failure, Kidney mt. 22:192 (1982).

    Article  CAS  Google Scholar 

  11. Y.G. Alevy, K.R. Mueller, and R.G. Slavin, Immune response in experimentally induced uremia. VI. Uremic macrophages are defective in their ability to present antigen to T cells. Clin Immunol and Immunopath. 29:433 (1983).

    Article  CAS  Google Scholar 

  12. B. Charpentier, P.H. Lang, B. Martin, J. Noury, D. Marthieu, and D. Fries, Depressed polymorphnuclear leucocyte functions associated with normal cytotoxic functions of T and nature Killer cells during chronic hemodialysis, Clin Nephrology. 19:288 (1983).

    CAS  Google Scholar 

  13. J. Nelson, D.J. Ormrod, and T.E. Miller, Host immune status in uremia. IV. Phagocytosis and inflammatory response in vivo. Kidney Int. 23:312 (1983).

    Article  PubMed  CAS  Google Scholar 

  14. K. Osaki, H. Otsuka, K. Uomizu, R. Harada, Y. Otsuji, and S. Hashimoto, Monocyte-mediated mitogen responses of lymphocytes in uremic patients. Nephron. 34:87 (1983).

    Article  PubMed  CAS  Google Scholar 

  15. J. Rubin, L.M. Lin, R. Lewis, J. Cruse, and J.D. Bower, Host defence mechanisms in contnuous ambulatory peritoneal dialysis. Clin Nephrology. 20:140 (1983).

    CAS  Google Scholar 

  16. M.D. Smith, G. Hardy, J.D. Williams, G.A. Coles, Suppressor cell numbers and activity in non-transfused renal dialysis patients. Clin Nephrology. 20:130 (1983).

    CAS  Google Scholar 

  17. Y.G. Alevy, R. Mueller, J.R. Anderson, P.S. Hutcheson, and R.G. Slavin, The role of monocytes and responder cells in suppression of antigen-specific T cell proliferation in chronic renal failure. Int Archs Allergy Appl Immun. 73:97 (1984).

    Article  CAS  Google Scholar 

  18. I. Jatoi, R.G. Slavin, and Y.G. Alevy, Immune response in experimental uremia. VII Uremic thymocytes amplify the response of control lymph node cells to alloantigens. Clin Immunol and Immunopath. 30:80 (1984).

    Article  CAS  Google Scholar 

  19. S. Mezzano, A.J. Pesce, V.E. Pollak, and J.G. Michael. Analysis of humoral and cellular factors that contribute to impaired immune responsiveness in experimental uremia. Nephron. 36:15 (1984).

    Article  PubMed  CAS  Google Scholar 

  20. J. Raskova, J. Ghobrial, S. Shea, R. Eisinger, and K. Raska jr.. Suppressor cells in end-stage renal disease. Functional assays and monoclonal antibody analysis. Am J Med. 76:847 (1984).

    Article  PubMed  CAS  Google Scholar 

  21. W.C. Waltzer, R.J. Bachvaroff, A.P. Raisbeck, B. Egelandsdal, C. Pullis, L. Shen, and F.T. Rapaport, Immunological monitoring in patients with end-stage renal disease. J Clin Immunol. 4:364 (1984).

    Article  PubMed  CAS  Google Scholar 

  22. E. Langhoff, and J. Ladefoged, In vitro natural killer and killer cell functions in uremia. Int Archs Allergy Appl Immun. 78:218 (1985).

    Article  CAS  Google Scholar 

  23. E. Mirapeix, J. Montolin, C. Suarez, J. Lopez Pedret, and L. Revert, Defective radioresistant suppressor cell activity in hemodialysis patients. Nephron. 41:184 (1985).

    Article  PubMed  CAS  Google Scholar 

  24. D. Donati, P. Cervini, O. Amatruda, L. Baratelli, D. Cassani, A. De Maio, G. Frattini, M. Martegani, and L. Gastaldi, Nutritional state and immune function in uremic patients on maintenance hemodialysis. Proc Int Symp on Immune and Metabolic Aspects of Therapeutic Blood Purification Systems, Trondheim 1985, ed. Smeby LL, Jørstad S, Widerøe T-E, Karger Basel, pp 303–309. (1986).

    Google Scholar 

  25. R.F. Gagnon, Delayed-type hypersensitivity skin reaction in the chronically uremic mouse: Influence of severity and duration of uremia on the development of response. Nephron. 43:16 U986).

    Google Scholar 

  26. P. Kurz, H. Köhler, S. Meuer, T. Hütteroth, and K-H Meyerzum Büschenfelde, Impaired cellular immune responses in chronic renal failure: Evidence of T cell defect, Kidney Int. 29:1209 (1986).

    Article  PubMed  CAS  Google Scholar 

  27. W.D. Tsakolos, Th.C. Theoharides, E.D. Kendler, J. Goffinet, J.M. Dwyer, R.L. Whisler, and P.W. Askenase, Immune defects in chronic renal impairment: evidence for defective regulation of lymphocyte response by macrophages from patients with chronic renal impairment on hemodialysis, Clin Exp Immunol. 63:218 (1986).

    PubMed  CAS  Google Scholar 

  28. I. Fehrman, O. Ringden, and J. Bergström, MLC-blocking factors in uremic sera, Clin Nephrol. 14:183 (1980).

    PubMed  CAS  Google Scholar 

  29. J. Raskova, and K. Raska, Humoral inhibitors of the immune response in uremia. IV. Effects of serum and of isolated serum very low density lipoprotein from uremic rats on cellular immune reactions in vitro. Lab Invest. 45:410 (1981).

    PubMed  CAS  Google Scholar 

  30. G. Delaporte, F. Gros, C. Jonsson, and J. Bergström, In vitro cytotoxic properties of plasma samples from uremic patients, Clin Nephrol. 17:247 (1982).

    PubMed  CAS  Google Scholar 

  31. K. Kamata, M. Okubo, and M. Sada, Immuno-suppressive factors in uremic sera are composed of both dialyzable and non-dialyzable components, Clin Exp Immunol. 54:277 (1983)

    PubMed  CAS  Google Scholar 

  32. P.K. Donnelly, B.K. Shenton, A.M. Alomran, D.M.A. Francis, G. Proud, and R.M.R. Taylor, N new mechanism of humoral immunosuppression in chronic renal failure and its importance to dialysis and transplantation, Proc Europ Dial Transpl Assoc. 20:297 (1983).

    CAS  Google Scholar 

  33. M. Rola-Pleszczynski, D. Bolduc, S. Forand, G.E. Plante, and S. St-Pierre, Cellular immune function in uremia: Altered cytotoxic and suppressor cell responses to an immunomodulating heptapeptide, Clin Immunol and Immuno- path. 28:177 (1984).

    Article  Google Scholar 

  34. P. Youing, J. Cledes, J.P. Herve, P. Miossec, and W.J.W. Morrow, Low-affinity E-rosette-blocking factor in hemo- dialysis-treated patients in chronic renal failure, Clin Immunol and Immunopath. 26:423 (1983).

    Article  Google Scholar 

  35. J.F. Mangan, C. Chikkappa, L. Bieler, W.B. Scharfman, and D.R. Parkinson, Regulation of human blood erythroid Burst-Forming-Unit (BFU-E) proliferation by FC receptors and monoclonal antibodies. Blood. 59:990 (1982).

    PubMed  CAS  Google Scholar 

  36. S. Lampari, and S. Carozzi, T lymphocytes, monocytes and erythropoiesis disorders in chronic renal failure. Nephron. 39:211 (1985).

    Article  Google Scholar 

  37. K.G. Chandy, M. Pähl, N.D. Vaziri, and S. Gupa, Acute effects of dialysis on T lymphocytes in patients with end-stage renal disease, J Clin Lab Immunol. 17:119 (1985).

    PubMed  CAS  Google Scholar 

  38. A.M. Badger, D.B. Bernard, B.A. Idelson, and S.R. Cooperband, Depressed spontaneous cellular cytotoxicity associated with normal or enhanced antibody-dependent cellular cytotoxicity in patients with chronic hemodialysis, Clin Exp Immunol. 45:563 (1981).

    Google Scholar 

  39. P. Jüngers, J.F. DeLagneaw, P. Prunet, and J. Crosnier, Vaccination against hepatitis B in hemodialysis centers, Adv Nephrol. 11:303 (1982).

    Google Scholar 

  40. H. Köhler, W. Arnold, G. Renschin, H.H. Dormeyer, and K.H. Meyerzum Buschenfelde, Active hepatitis B vaccination of dialysis patients and medical staff. Kidney Int. 25:124 (1984).

    Article  PubMed  Google Scholar 

  41. F.G. Casio, G.S. Giebink, C. Le Than, and G. Schiffman, Pneumococcal vaccination in patients with chronic renal disease and renal allograft recipiens. Kidney Int. 20: 254 (1981).

    Article  Google Scholar 

  42. R. Cappel, D. Beers, C. Liesnard, and M. Sratwa, Impaired humoral and cell-mediated immune responses in dialyzed patients after influenza vaccination, Nephron. 33:21 (1983).

    Article  PubMed  CAS  Google Scholar 

  43. J. Nikoskelainen, M. Koskela, J. Forsström, A. Kasanen, and M. Leinonen, Persistence of antibodies to pneumococcal vaccine in patients with chronic renal failure. Kidney Int. 28;672 (1985).

    Article  PubMed  CAS  Google Scholar 

  44. D. Urbanitz, and H.G. Sieberth, Impaired phagocytic activity of human monocytes in respect to reduced antibacterial resistance in uremia, Clin Nephrol. 4:13 (1975).

    PubMed  CAS  Google Scholar 

  45. G. Lahnborg, L. Berghem, T. Ahlgren, L-G Groth, G. Lundgren, and A. Tillegard, Reticuloendothelial function in human renal allograft recipients. Transplantation. 28: 111 (1979).

    Article  PubMed  CAS  Google Scholar 

  46. T.M. Saba, Physiology and physiopathology of the reticuliendothelial system. Arch Intern Med. 126:1031 (1970).

    Article  PubMed  CAS  Google Scholar 

  47. K.L. Rosenstreich, J.J. Farrar, and S. Dougherty, Absolute macrophage dependency of T lymphocyte activation by mitogens. J Immunol. 116:131 (1976).

    PubMed  CAS  Google Scholar 

  48. J. Knop, Influence of various macrophage population on Con A induced T cell proliferation. Immunology 41:379 (1980).

    PubMed  CAS  Google Scholar 

  49. S.A. Rosenberg, and P.E. Lipsky, The role of monocyte factors in the differentiation of Immunglobulin secreting cells from human peripheral blood B cells. J Immunol. 125:232 (1980).

    PubMed  CAS  Google Scholar 

  50. F.G. Meyling, and T.A. Waldmann, Human B cell activation in vitro: augmentation and suppression by monocytes of the Immunglobulin production induced by various B cell stimulants. J Immunol. 126:529 (1981).

    Google Scholar 

  51. D. Metcalf, C.G. Begley, G.R. Johnson, N.A. Nicola, M.A. Vadas, A.F. Lopez, D.J. Williamson, G.G. Wong, S.C. Clark, and E.A. Wang, Biologic properties in vitro of a recombinant human granulocyte-macrophage colony- stimulating factor. Blood 67:37 (1986).

    PubMed  CAS  Google Scholar 

  52. O. Bakke, T. Balstad, L.C. Smeby, S. Jørstad, and T-E. Widerøe, Mononuclear cells (monocytes (OK 141+), T. and Tg+ cells) during hemodialysis. Proc Int Symp on litoune and Metabolic Aspects of Therapeutic Blood Purification Systems, Trondheim 1985, ed. Smeby L.C, Jøirstad S, Widerøe T-E, Karger Basel, pp 105–111 (1986).

    Google Scholar 

  53. R. Korz, U. Loe Guitz, B. Brunner, and R. Heinz, Lymphocyte enzymes of DNA synthesis in chronic renal failure. Proc Eur Dial Transpl Assoc. 13:528 (1976).

    Google Scholar 

  54. R.A. Gutman, and A.T. Auang, Inhibitor, of marrow thymidine incorporation from sera of patients with uremia. Kidney Int. 18:715 (1980).

    Article  PubMed  CAS  Google Scholar 

  55. E.N. Wardle, A study of the possible toxic metabolites of uremia in red cell metabolism. Acta Haematol. 43:129 (1970).

    Article  PubMed  CAS  Google Scholar 

  56. M. Kurada, T. Asaka, Y.M. Tofuku, and R. Takeda, Serum antioxidant activity in uremic patients. Nephron. 41: 293 (1985).

    Article  Google Scholar 

  57. M. Taccone-Galluci, O. Giardini, R. Lubrano, U. Mazzarella, D. Bardino, S. Khashan, O. Mannarino, M. Elli, M. Cozzari, U. Bounteristiani, and C.U. Casciani, Red blood cell membrane lipid peroxidation in continuous ambulatory peritonal dialysis patients. Am J Nephrol. 6:92 (1986).

    Article  Google Scholar 

  58. S. Jørstad and K. E. Viken, Inhibitory effects of plasma from uraemic patients on human mononuclear phagocytes cultured in vitro. Acta Path Microbiol Scand Sect C 859:169 (1977).

    Google Scholar 

  59. S. Jørstad, and S. Kvaernes, Uraemic toxins of high molecular weight inhibiting human mononuclear phagocytes cultured in vitro. Acta Path Microbiol Scand Sect C 86: 221 (1978).

    Google Scholar 

  60. S. Jørstad, L.C. Smeby, T-E. Widerøe, and K.J. Berg, Transport of uremic toxius through conventional hemodialysis membranes. Clin Nephrol. 12:168 (1979).

    PubMed  Google Scholar 

  61. L.K. Curtiss, and T.S. Edgington, Differential sensitivity of lymphocyte subpopulation to suppression by low density lipoprotein inhibitor, an immunoregulatory human serum low density lipoprotein. J Clin Invest. 63:193 (1979).

    Article  PubMed  CAS  Google Scholar 

  62. D. Modai, J. Weissgarten, U. Shaked, S. Segal, A. Pik, and R. Fuchs, Levamisole circumvents inhibition of lymphocyte activation imposed by uremic serum. Nephron. 40:436 (1985).

    Article  PubMed  CAS  Google Scholar 

  63. P.A. Peterson, P.E. Ervin, and J. Berggard, Differentiation of glomerular, tubular, and normal proteinuria: determinations of urinary excretion of ß2-microglobulin, albumin and total protein, J Clin Invest. 48:1189 (1969).

    Article  PubMed  CAS  Google Scholar 

  64. R.E. Birch, M.W. Fanger, and G.M. Bernier, ß2-microglobulin enhances lymphocyte surface receptor expression for IgG. J Immunol. 122:997 (1979).

    PubMed  CAS  Google Scholar 

  65. P.A. Keown, and B. Descamps, Improved renal graft survival after blood transfusion: a nonspesific erythrocyte mediated immunoregulatory process. Lancet 1:20 (1979).

    Article  PubMed  CAS  Google Scholar 

  66. B.S. Bender, J.L. Curtis, J.E. Nagel, F.J. Chrest, E.S. Kraus, G.R. Briefel, and W.H. Adler, Analysis of immune status of hemodialyzed adults: association with prior transfusions. Kidney Int. 26:436 (1984).

    Article  PubMed  CAS  Google Scholar 

  67. R.M. Hakim, D.T. Fearon, M. Lazarus, and C.S. Perzanowski, Biocompatibility of dialysis membranes: effects of chronic complement activation. Kidney Int. 26:194 (1984).

    Article  PubMed  CAS  Google Scholar 

  68. A.K. Cheung, D.E. Chenoweth, D. Otsuka, and L.W. Henderson, Compartmental distribution of complement activation products in artificial kidneys. Kidney Int. 30:74 (1986).

    Article  PubMed  CAS  Google Scholar 

  69. L. C. Smeby, S. Jørstad, T. Balstad, and T-E. Widerøe, Dialyzer generation and plasma clearance of activated complement during hemodialysis. Proc Int Symp on Immune and Metabolic Aspects of Therapeutic Blood Purification Systems. Trondheim 1985, ed. Smeby LC, Jørstad S, Widerøe T.E, Karger Basel, pp 303 (1986).

    Google Scholar 

  70. D.E. Chenoweth, and T.E. Hugli, Demonstration of specific Cc- receptor on intact human polymorphonuclear leucocytes. Proc Nath Acad Sci USA 75 (8), 3943 (1978).

    Article  CAS  Google Scholar 

  71. S.L. Lewis, D.E. Van Epps, and D.E. Chenoweth, C5a- receptor modulation on neutrophils and monocytes from chronic hemodialysis and peritoneal dialysis patients. Clin Nephrol. 26:37 (1986).

    PubMed  CAS  Google Scholar 

  72. R.M. Hakim, J. Breillatt, J.M. Lazarus, and F.K. Port, Complement activation and hypersensitivity reactions to dialysis membranes. Engl j Med. 311:878 (1984).

    Article  CAS  Google Scholar 

  73. S. Stefoni, A.N. Costa, M.P. Scolar, L. Coli, G. Mosconi, A. Buscaroli, P. Boni, S. lannelli, T. D. Atena, G. Cianciolo, L. Bruni, and U. Bonomini, DNA-content and surface antigen characteristics of T-cell subsets in chronic dialysis patients. Proc Int Symp on Immune and Metabolic Aspects of Therapeutic Blood Purifcation Systems, Trondheim 1985, ed. Smeby LC, Jørstad S, Widerøe T-E, Karger Basel pp 168 (1986).

    Google Scholar 

  74. Y. Chida, S. Sakurai, and N. Yoshiyama, The effect of hemo dialysis on lymphocyte subsets during dialysis. Clin Nephrol. 25:159 (1986).

    PubMed  CAS  Google Scholar 

  75. M. Bingel, G. Lonnemann, S. Shaldon, K.M. Koch, and C.A. Dinarello, Human interleucin-1 production during hemodialysis. Nephron. 43:161 (1986).

    Article  PubMed  CAS  Google Scholar 

  76. J.E. Hefti, A. Blumberg, and H.R. Marti, Red cell survival and red cell enzymes in patients on continuous peritoneal dialysis (CAPD). Clin Nephrol. 19:232 (1983).

    PubMed  CAS  Google Scholar 

  77. R. Lerner, B. Werner, H. Asaba, B. Ternstedt, and E. Elmqvist, Assessment of hemodialysis in regular hemodialysis patients by measuring carbon monoxide production rate. Clin Nephrol. 20:239 (1983).

    PubMed  CAS  Google Scholar 

  78. C.R. Angle, M.S. Swanson, S.J. Stohs, and R.S. Markin, Abnormal erythrocyte pyrimidin nucleotides in uremic subjects. Nephron. 39:169 (1985).

    Article  PubMed  CAS  Google Scholar 

  79. G. Goubeaud, H.W. Leber, H.H. Schott, and G. Schütterle, Middle molecules and haemoglobulin synthesis. Proc Europ Dial Transpl Assoc. 13:371 (1976).

    Google Scholar 

  80. R.A. Gutman, A.T. Huang, and N.S. Bouknight, Inhibitor of marrow thymidin incorporation from sera of patients with uremia. Kidney Int. 18:715 (1980).

    Article  PubMed  CAS  Google Scholar 

  81. H.W. Radtke, A.B. Rege, M.B. LaMarche, and D. Bartos. Identification of spermine as an inhibitor of Erythro- poiesis in patients with chronic renal failure. Clin Invest. 67:1623 (1981).

    Article  CAS  Google Scholar 

  82. R.J.S. McGonigle, J.D. Wallin, R.K. Shadduck, and J.W. Fischer, Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency. Kidney Int. 25:437 (1984).

    Article  PubMed  CAS  Google Scholar 

  83. T.E. Widerøe, T. Sanengen, and S. Halvorsen, Erythropoietin and uremic toxicity during continuous ambulatory dialysis. Kidney Int. 24, Suppl 16, 208 (1983).

    Google Scholar 

  84. F. Delwiche, G.M. Segal, J.W. Eschbach, and J.W. Adamson, Hematopoietic inhibitors in chronic renal failure: lack of in vitro specificity. Kidney Int. 29:641 (1986).

    Article  PubMed  CAS  Google Scholar 

  85. J.W. Fisher, Mechanism of the anemia of chronic renal failure. Nephron. 25:106 (1980).

    Article  PubMed  CAS  Google Scholar 

  86. W. Fried, and A. Anagnoston, Extrarenal erythropoietin production. In: Kidney Hormones, ed. Fischer J.W. vol. II:pp 231 (Academic Press, London 1977).

    Google Scholar 

  87. J. Caro, and A.J. Erslev, Uremic inhibitors of erythropoiesis. Semin Nephrol. 5:128 (1985).

    PubMed  CAS  Google Scholar 

  88. B.P. Spragg, D.P. Bentley, and G.A. Coles, Anaemia of chronic renal failure. Polyamines are not raised in uremic serum. Nephron. 38:65 (1984).

    Article  PubMed  CAS  Google Scholar 

  89. D. Meytes, E. Bogin, A. Ma, P.P. Dukes, and S.G. Massry, Effect of parathyroid hormone on erythropoiesis. J Clin Invest. 67:1263 (1981).

    Article  PubMed  CAS  Google Scholar 

  90. F. Delwiche, M.J. Garrity, J.S. Powell, R.P. Robertson, and J.W. Adamson, High level of the circulating form of parathyreoid hormone do not inhibit in vitro erythropoiesis. J Lab Clin Med. 102:613 (1983).

    PubMed  CAS  Google Scholar 

  91. J.B. Sherwood, and E. Goldwasser, A radioimmunoassay for erythropoietin. Blood 54:885 (1979).

    PubMed  CAS  Google Scholar 

  92. P.M. Cotes, Immunoreactive erythropoietin in serum. I. Evidence of the validity of the assay method and the physiological relevance of estimates. Br J Hemat. 50:427 (1983).

    Google Scholar 

  93. M.C. Bordas, N.S. Serbource-Goguel, J.M. Feger, J.M. Maccario, J.M. Agneray, and G.M. Durand, Evaluation of the degree of desialynation of serum a--acid glucoprotein and a.-antitrypsin. Clin Chim Acta. 125:311 (1982).

    Article  PubMed  CAS  Google Scholar 

  94. H. Lewinsky, U. Gafter, J. Levi, and D. Allalouf, Neuramidase-like activity in sera of uremic anemic patients, Nephron. 37:35 (1984).

    Article  Google Scholar 

  95. J.S. Shannon, T.R.J. Lappin, G.E. Elder, G.M. Roberts, M.G. McGeown, and J.M. Bridges, Increased plasma glycosidase and protease activity in uraemia: possible role in the aetiology of the anaemia of chronic renal failure. Clin Chim Acta. 153:203 (1985).

    Article  PubMed  CAS  Google Scholar 

  96. J.I. Kurland, A. Meyors, and M.A.S. Moore, Synthesis and release of erythroid colony-and burst-potentiating activities by purified populations of murine peritoneal macrophages. J Exp Med. 151:839 (1980).

    Article  PubMed  CAS  Google Scholar 

  97. J.N. Rich, W. Heit, and B. Kubanek, An erythropoietic stimulating factor similar to erythropoietin released by macrophages after treatment with silica. Blut 4: 297 (1980).

    Google Scholar 

  98. K. Jacobs, C. Shoemaker, R. Rudersdorf, S.D. Neill, R.J. Kaufman, A. Mufson, J. Seehra, S.S. Jones, R. Hewich, E.F. Fritsch, M. Kawakita, T. Shimizu, and T. Miyake, Isolation and characterization of genomic and cDNA clones of human erythropoietin. Nature 313:806 (1985).

    Article  PubMed  CAS  Google Scholar 

  99. J.W. Eschbach, J. Mladenovic, J. F. Garcia, P. W. Wahl, and J. W. Adamson, The anemia of chronic renal failure sheep. Response to erythropoietin-rich plasma in vivo. J Clin Invest. 74:434 (1984).

    Article  PubMed  CAS  Google Scholar 

  100. J. Mladenovic, J.W. Eschbach, J.R. Koup, J.F. Garcia, and J.W. Adamson, Erythropoietin kinetics in normal and uremic sheep. J Lab Clin Med. 195:659 (1985).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nephrology, University hospital of Trondheim, Norway

    Tor-Erik Widerøe

Authors
  1. Tor-Erik Widerøe
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Ghent, Ghent, Belgium

    Severin Ringoir  & Raymond Vanholder  & 

  2. University of Southern California, Los Angeles, California, USA

    Shaul G. Massry

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Plenum Press, New York

About this chapter

Cite this chapter

Widerøe, TE. (1987). Uremic Dysmetabolism and Its Effect on Immunocompetent and Erythroid Cell Function. In: Ringoir, S., Vanholder, R., Massry, S.G. (eds) Uremic Toxins. Advances in Experimental Medicine and Biology, vol 223. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5445-1_28

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5445-1_28

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5447-5

  • Online ISBN: 978-1-4684-5445-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation